James French Hill Periodic Transaction Report

Filed Feb 4, 2025 · House Clerk · 1 transaction

U.S. Representative · R · AR-02 · All trades by James French Hill

On February 4, 2025, Rep. James French Hill (R-AR-02) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Jan 31, 2025.

The filing covers 1 ticker, including $CVS.

Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.

Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 4 days.

Source document: House Clerk filing 20026706

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

James French Hill · Sold $CVS · Jan 31 · $15K–$50K

0.65HIGH
Disclosure speedx 0.251.00
Trade sizex 0.250.50
Cluster activityx 0.150.30

1 other member traded this name in the same window.

Track recordx 0.350.67

Coldpine’s read

Hill sits on House Financial Services, giving him oversight relevance to CVS's insurance and pharmacy-benefit operations. The 4-day disclosure lag is fast, meaning the market may not have fully absorbed the filing. One other member traded CVS in the same direction within 30 days, indicating minor cluster activity.

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow James French Hill

Get an email the moment James French Hill files the next one. Free, no card, no spam.

Follow free →
1
Transactions
0 / 1
Buys / sales
1
Tickers
4d
Longest lag

Tickers in this filing

Transactions disclosed

Trade dateTickerAssetTypeOwnerAmountLag
Jan 31, 2025CVS
CVS Health Corporation Common Stock (CVS)
sell—$15K–$50K4d

The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.

Other recent filings by James French Hill

← All congressional filings, newest firstFiled Feb 4, 2025February 2025 archive

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →